Pattern of use of intravitreal drugs with antiangiogenic properties for age-related macular degeneration and other vascular retinopathies (Anti-VEGF drugs)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/16444
• EU PAS number:
  EUPAS15749
• Study ID:
  16444
• Official title and acronym:
  Pattern of use of intravitreal drugs with antiangiogenic properties for age-related macular degeneration and other vascular retinopathies (Anti-VEGF drugs)
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  This is a drug utilization study of antiVEGF drugs for the treatment of age related macular degeneration and other vascular retinopathies in clinical practice, in the Tuscany region of Italy, from 2011 to 2015
• Study status:
  Finalised

Research institutions and networks

Institutions

Agenzia regionale di sanità della Toscana (ARS)

Italy

Study timelines

Date when funding contract was signed

Planned: 09/03/2016

Actual: 03/03/2016

Study start date

Planned: 05/09/2016

Actual: 05/09/2016

Data analysis start date

Planned: 12/09/2016

Actual: 12/09/2016

Date of final study report

Planned: 17/10/2016

Actual: 28/11/2016

Sources of funding

Other

More details on funding

Self-funded by ARS

Study protocol

Initial protocol

Pattern of use drugs for AMD treatment_to_publish

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable